Pozen and Tribute Announce Plan to Proceed with Merger
Troutman Sanders was mentioned in a December 9 GlobalData Financial Deals Tracker article about Pozen Inc, a developer of pharmaceutical products for acute and chronic pain, and Tribute Pharmaceuticals Canada Inc., a specialty pharmaceutical company, having amended their acquisition agreement and announcing that they have entered into a merger agreement. The combined company will be named Aralez Pharmaceuticals Inc. and will be based in Canada.
Troutman Sanders corporate lawyers Tom Rose, David Ghegan, Shona Smith, Lisa Raines and Kristen O’Connor; tax lawyer Mark Goldsmith and Robert Friedman; IP lawyer Heather Ettinger and team; benefits and employment lawyer Jeff Banish and team; lending lawyer Mike Karpen; HSR lawyer Mitch Portnoy; and CFIUS lawyer Megan Rahman served as U.S. legal counsel for Tribute in the deal.